• Featured Product
  • KD/KO Validated

SEMA3C Polyclonal antibody

SEMA3C Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 19242-1-AP

Synonyms

Sema E, SEMA3C, SEMAE, Semaphorin 3C, Semaphorin E, SemE



Tested Applications

Positive WB detected inmouse heart tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

19242-1-AP targets SEMA3C in WB, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SEMA3C fusion protein Ag5480
Full Name sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
Calculated Molecular Weight 85 kDa
Observed Molecular Weight 70 kDa
GenBank Accession NumberBC030690
Gene Symbol SEMA3C
Gene ID (NCBI) 10512
RRIDAB_10858635
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

SEMA3C (Semaphorin 3C) is associated with tumor progression and poor prognosis across multiple tumor types, including pancreatic, gastric, prostate, and breast cancer, as well as glioma. It is worth noting that full-length SEMA3C has also been reported as a tumor suppressor factor by suppressing tumor lymphangiogenesis and metastasis (PMID: 31649890).

Protocols

Product Specific Protocols
WB protocol for SEMA3C antibody 19242-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Front Oncol

SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis.

Authors - Ruoyan Liu
  • KD Validated
humanWB

Front Oncol

SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment.

Authors - Dalin Zhang
  • KO Validated